TENOFOVIR ALAFENAMIDE FUMARATE

Clinical trials for TENOFOVIR ALAFENAMIDE FUMARATE explained in plain language.

Never miss a new study

Get alerted when new TENOFOVIR ALAFENAMIDE FUMARATE trials appear

Sign up with your email to follow new studies for TENOFOVIR ALAFENAMIDE FUMARATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug tested to stop moms from passing hepatitis b to babies

Prevention Recruiting now

This study is testing a newer hepatitis B medicine called TAF in pregnant women who have the virus. The main goal is to see if TAF is safe and effective at preventing the mother from passing hepatitis B to her baby during pregnancy and birth. Researchers will measure drug levels …

Matched conditions: TENOFOVIR ALAFENAMIDE FUMARATE

Phase: PHASE4 • Sponsor: First People's Hospital of Hangzhou • Aim: Prevention

Last updated Mar 09, 2026 14:25 UTC

TENOFOVIR ALAFENAMIDE FUMARATE

Get alerted when new TENOFOVIR ALAFENAMIDE FUMARATE trials appear

New drug tested to stop moms from passing hepatitis b to babies